InvestorsHub Logo
Post# of 252235
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: DewDiligence post# 147714

Sunday, 08/26/2012 2:22:42 PM

Sunday, August 26, 2012 2:22:42 PM

Post# of 252235
In DEFINE study anacetrapib also increased HDL-C by 138%, if HDL is active it might compensate, but if the benefit of anacetrapib on reduction in CV events is solely derived from LDL-C reduction, then this of course bearish.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.